CHronic Nonbacterial Osteomyelitis International Registry
CHronic Nonbacterial Osteomyelitis International Registry (CHOIR)
Seattle Children's Hospital
2,000 participants
Aug 1, 2018
OBSERVATIONAL
Conditions
Summary
The objective of the study is to establish a prospective disease registry for chronic recurrent multifocal osteomyelitis (CRMO)/chronic nonbacterial osteomyelitis (CNO) in order to investigate the natural history of the disease and the responses of patients to different clinical managements over 10 years.
Eligibility
Inclusion Criteria4
- \- Age at enrollment is equal to or younger than 21 years of age
- Presence of bone edema on STIR or T2 fat saturation sequence on MRI within 12 weeks of enrollment
- Whole body imaging evaluation (either WB MRI or bone scintigraphy)
- Bone biopsy to exclude infection or malignancy unless bone lesions follow typical distribution or there is IBD, psoriasis, or palmar plantar pustulosis
Exclusion Criteria3
- \- History of or current malignancy
- Current infectious osteomyelitis
- Contraindication to the selected treatment agent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
second-line treatment for children with CNO/CRMO after failure to respond to NSAIDs
second-line treatment for children with CNO/CRMO after failure to respond to NSAIDs
second-line treatment for children with CNO/CRMO after failure to respond to NSAIDs
second-line treatment for children with CNO/CRMO after failure to respond to NSAIDs
second-line treatment for children with CNO/CRMO after failure to respond to NSAIDs
second-line treatment for children with CNO/CRMO after failure to respond to NSAIDs
second-line treatment for children with CNO/CRMO after failure to respond to NSAIDs
second-line treatment for children with CNO/CRMO after failure to respond to NSAIDs
second-line treatment for children with CNO/CRMO after failure to respond to NSAIDs
second-line treatment for children with CNO/CRMO after failure to respond to NSAIDs
first-line treatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04725422